However, it has been reported that EMP 3 is more frequently methylated in neuroblastoma than in PCC (methylation rate: 68.4% versus 6.1%), which could explain the retainment of EMP 3 expression in PCC [76]. Here, EMP3 is linked to neuroblastoma.